Advertisement
Screener

BridgeBio Pharma, Inc. (BBIO) Executive Pay versus Performance: Pay versus Performance

BridgeBio Pharma, Inc. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Dr. Kumar; PEO total compensation $14.94M; PEO compensation actually paid $75.35M; Other NEO average total compensation $3.26M.
  • 2024-12-31: PEO Dr. Kumar; PEO total compensation $15.58M; PEO compensation actually paid -$2.66M; Other NEO average total compensation $6.08M.
  • 2023-12-31: PEO Dr. Kumar; PEO total compensation $12.16M; PEO compensation actually paid $70.06M; Other NEO average total compensation $6.65M.
  • 2022-12-31: PEO Dr. Kumar; PEO total compensation $6.67M; PEO compensation actually paid -$11.34M; Other NEO average total compensation $2.96M.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Dr. Kumar$14.94M$75.35M$3.26M$22.56M$108.00$125.00revenue
$502.08M
2026-04-24
2024-12-31Dr. Kumar$15.58M-$2.66M$6.08M-$261.16K$39.00$93.00$221.90M2026-04-24
2023-12-31Dr. Kumar$12.16M$70.06M$6.65M$29.07M$57.00$94.00$9.30M2026-04-24
2022-12-31Dr. Kumar$6.67M-$11.34M$2.96M-$783.73K$11.00$90.00$77.65M2026-04-24
2021-12-31Dr. Kumar$25.63M-$132.75M$8.68M-$23.12M$23.00$100.00$69.72M2026-04-24
2024-12-31Dr. Kumar$15.58M-$2.66M$6.08M-$261.16K$78.00$118.00revenue
$221.90M
2025-04-30
2023-12-31Dr. Kumar$12.16M$70.06M$6.65M$29.07M$115.00$119.00$9.30M2025-04-30
2022-12-31Dr. Kumar$6.67M-$11.34M$2.96M-$783.73K$22.00$114.00$77.65M2025-04-30
2021-12-31Dr. Kumar$25.63M-$132.75M$8.68M-$23.12M$48.00$126.00$69.72M2025-04-30
2020-12-31Dr. Kumar$10.05M$151.06M$4.76M$18.43M$203.00$126.00$8.25M2025-04-30
2023-12-31Dr. Kumar$12.16M$70.06M$6.65M$29.07M$115.00$119.00-$643.20Mrevenue
$9.30M
2024-04-25
2022-12-31Dr. Kumar$6.67M-$11.34M$2.96M-$783.73K$22.00$114.00-$481.18M$77.65M2024-04-25
2021-12-31Dr. Kumar$25.63M-$132.75M$8.68M-$23.12M$48.00$126.00-$562.54M$69.72M2024-04-25
2020-12-31Dr. Kumar$10.05M$151.06M$4.76M$18.43M$203.00$126.00-$448.72M$8.25M2024-04-25
2022-12-31Dr. Kumar$6.67M-$11.34M$2.96M-$783.73K$22.00$114.00-$481.18MRevenue
$77.65M
2023-04-28
2021-12-31$25.63M-$132.75M$8.68M-$23.12M$48.00$126.00-$562.54M$69.72M2023-04-28
2020-12-31$10.05M$151.06M$4.76M$18.43M$203.00$126.00-$448.72M$8.25M2023-04-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52